A novel amyloidogenic variant of apolipoprotein Al: Implications for a conformational change leading to cardiomyopathy

American Journal of Pathology

Volumn 154, Issue 1, 1999, Pages 11-14

  Walsh, M T ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1;

AMYLOIDOSIS; CARDIOMYOPATHY; CONFORMATIONAL TRANSITION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION;

EID: 0032918099     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65244-3     Document Type: Note

References (37)

1. M Skinner AS Cohen Amyloidosis JP Kassirer Current Therapy in Internal Medicine 1991 Decker BC, Inc. Philadelphia 1548 1553
2. GG Glenner Amyloid deposits and amyloidosis: the β-fibrilloses N Engl J Med 302 1980 1283 1292 1333–1343
3. MJ Stone Amyloidosis: a final common pathway for protein deposition in tissues Blood 75 1990 531 545
4. RH Falk RL Comenzo M Skinner The systemic amyloidoses N Engl J Med 337 1997 898 909
5. JW Kelly Alternative conformations of amyloidogenic proteins govern their behavior Curr Op Struct Biol 6 1996 11 17
6. MD Benson Amyloidosis CR Scriver WS Sly D Valle The metabolic and molecular bases of inherited diseases 1995 McGraw-Hill New York 4159 4191
7. P Westermark K Sletten B Johansson GG Cornwell III Fibril in senile systemic amyloidosis is derived from normal transthyretin Proc Natl Acad Sci USA 87 1990 2843 2845
8. M Skinner Familial amyloidotic cardiomyopathy J Lab Clin Med 117 1991 171 172
9. LH Asl JJ Liepnieks KH Asl T Uemichi G Moulin E Desjoyaux R Loire M Delpech G Grateau MD Benson Hereditary amyloid cardiomyopathy Am J Pathol 154 1999 221 227
10. D Atkinson DM Small Recombinant lipoproteins: implications for structure and assembly of native lipoproteins Annu Rev Biophys Chem 15 1986 403 456
11. AM Gotto Jr HJ Pownall RJ Havel Introduction to the plasma lipoproteins Methods Enzymol 128 1986 3 40
12. MS Brown JL Goldstein Receptor-mediated control of cholesterol metabolism Science 191 1976 150 154
13. EJ Schaefer WH Heaton MG Wetzel HB Brewer Jr Plasma apolipoprotein AI absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease Arteriosclerosis 2 1982 16 26
14. S Xu M Laccotripe X Huang A Rigotti VI Zannis M Krieger Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-B1, an HDL receptor that mediates selective lipid uptake J Lipid Res 38 1997 1289 1298
15. VI Zannis SK Karathanasis GM Forbes JL Breslow Intra- and extracellular modifications of apolipoproteins Methods Enzymol 128 1986 690 712
16. JP Segrest A molecular theory of lipid-protein interactions in the plasma lipoproteins FEBS Lett 38 1974 247 253
17. AR Tall GG Shipley DM Small Conformational and thermodynamic properties of apoAI of human plasma high density lipoproteins J Biol Chem 251 1976 3749 3755
18. O Gursky D Atkinson Thermal unfolding of human high density apolipoprotein AI: implications for a lipid-free molten globular state Proc Natl Acad Sci USA 93 1996 2991 2995
19. JR Wetterau LP Aggerbeck SC Rall Jr KH Weisgraber Human apolipoprotein E3 in aqueous solution 1. evidence for two structural domains J Biol Chem 263 1988 6240 6248
20. C Edelstein AM Scanu Effect of guanidine hydrochloride on the hydrodynamic and thermodynamic properties of human apolipoprotein AI in solution J Biol Chem 255 1980 5747 5754
21. JP Segrest H DeLoof JG Dohlman CG Brouillette GM Anantharamaiah Amphipathic helix motif: classes and properties Proteins 8 1990 103 117
22. RT Nolte D Atkinson Conformational analysis of apolipoprotein AI and E3 based on primary sequence and circular dichroism Biophys J 63 1992 1221 1239
23. PG Frank D N′Guyen V Franklin T Neville M Desforges E Rassart DL Sparks YL Marcel Importance of central α-helices of human apolipoprotein AI in the maturation of high density lipoproteins Biochemistry 37 1998 13902 13909
24. DR Breiter MR Kanost MM Benning G Wesenburg JH Law MA Wells I Rayment HM Holden Molecular structure of an apolipoprotein determined at 2.5Å resolution Biochemistry 30 1991 603 608
25. C Wilson MR Wardell KH Weisgraber RW Mahley DA Agard Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E Science 252 1991 1817 1822
26. YL Marcel PR Provost H Koa E Raffai NV Dac J-C Fruchart E Rassart The epitopes of apolipoprotein AI define distinct structural domains including a mobile middle region J Biol Chem 266 1991 3644 3653
27. CL Banka DJ Bonnet AS Black RS Smith LK Curtiss Localization of an apolipoprotein AI epitope critical for activation of lecithin-cholesterol acyl-transferase J Biol Chem 266 1991 23886 23892
28. WC Nichols RE Gregg HB Brewer Jr MD Benson A mutation in apo-lipo-protein AI in the Iowa type of familial amyloidotic polyneuropathy Genomics 8 1990 318 323
29. LA Jones JA Harding AS Cohen M Skinner New USA family has apolipo-protein AI (Arg26) variant JB Natvig O Forre G Husby A Husebekk B Skøgen K Sletten P Westermark Amyloid and Amyloidosis 1990 Kluwer Academic Publishers Boston/London 385 388
30. DM Vigushin J Gough D Allan A Alguacil B Penner NM Pettigrew G Quinonez K Bernstein SE Booth DR Booth AK Soutar PN Hawkins MB Pepys Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg 26 QJM 87 1994 149 154
31. AK Soutar PN Hawkins DM Vigushin GA Tennent SE Booth T Hutton A Nguyen NF Totty JJ Hsuan MB Pepys Apolipoprotein AI mutation Arg 60 causes autosomal dominant amyloidosis Proc Natl Acad Sci USA 89 1992 7389 7393
32. DR Booth S-Y Tan SE Booth JJ Hsuan NF Totty O Nguyen T Hutton DM Vigushin GA Tennent WL Hutchinson N Thomson AK Soutar PN Hawkins MB Pepys A new apolipoprotein AI variant, Trp 50 Arg, causes hereditary amyloidosis QJM 88 1995 695 702
33. DR Booth S-Y Tan SE Both GA Tennent WL Hutchinson JJ Hsuan NF Totty O Truong AK Soutar PN Hawkins M Bruguera J Caballería M Sole JM Campistol MB Pepys Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene J Clin Invest 97 1996 2714 2721
34. MR Persey DR Booth SE Booth R van Zyl-Smit BK Adams AB Fattaar GA Tennent PN Hawkins MB Pepys Hereditary nephropathic systemic amyl-oidosis caused by a novel variant apolipoprotein AI Kidney Int 53 1998 276 281
35. DJ Rader RE Gregg MS Meng JR Schaefer LA Zech MD Benson HB Brewer Jr In vivo metabolism of a mutant apolipoprotein, apoAIIOWA, associated with hypoalphalipoproteinemia, and hereditary systemic amyloidosis J Lipid Res 33 1992 755 763
36. D Atkinson Apolipoprotein structure: crystals and models Curr Op Struct Biol 2 1992 482 489
37. MD Benson Apolipoprotein AI, and amyloidosis: a genetic model for aging Kidney Int 53 1998 508 509